Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors
Tommaso Clemente(Vita-Salute San Raffaele University), Antonella Castagna(Vita-Salute San Raffaele University), Riccardo Lolatto(Vita-Salute San Raffaele University), Roberta Gagliardini(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Giovanni Cenderello(Ente Ospedaliero Ospedali Galliera), Maria Mercedes Santoro(University of Rome Tor Vergata), Anna Maria Cattelan(University of Padua), Adriana Cervo(Azienda Ospedaliero-Universitaria di Modena), Emanuele Focà(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Leonardo Calza(University of Bologna), Filippo Lagi(Policlinico Umberto I), Laura Galli(Vita-Salute San Raffaele University), Stefano Rusconi(University of Milan), Vincenzo Spagnuolo(Vita-Salute San Raffaele University), Giulia Marchetti(University of Milan), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Maurizio Zazzi(University of Siena), Sergio Ferrara(University of Turin), Antonio Di Biagio
Cited by 21
Related Papers
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019
|Annals of Neurology|2020|299
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses
|Clinical Infectious Diseases|2021|179
Mpox in people with past infection or a complete vaccination course: a global case series
|The Lancet Infectious Diseases|2023|141
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
|PLoS ONE|2020|128